431 filings
NT 20-F
IPCIF
Intellipharmaceutics International Inc.
2 Apr 24
Notice of late annual filing (foreign)
9:03pm
6-K
IPCIF
Intellipharmaceutics International Inc.
13 Mar 24
Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan
8:06pm
6-K
IPCIF
Intellipharmaceutics International Inc.
7 Mar 24
Intellipharmaceutics Announces Cease Trade Order
3:21pm
6-K
IPCIF
Intellipharmaceutics International Inc.
26 Feb 24
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form
9:11pm
UPLOAD
IPCIF
Intellipharmaceutics International Inc.
14 Feb 24
Letter from SEC
12:00am
6-K
zd0p1
9 Feb 24
Intellipharmaceutics International Inc. Announces Stock Option Grant
12:00am
20-F/A
oey 7ty5s
6 Feb 24
Annual report (foreign) (amended)
12:00am
6-K
zj7g4ak nybgp
11 Jan 24
Intellipharmaceutics International Inc. Receives Conditional Approval to List on the TSX Venture Exchange
6:14pm
6-K
l70imh1y 84p84
16 Oct 23
Current report (foreign)
5:23pm
6-K
47c2enp
6 Oct 23
Annual Meeting of Shareholders
11:33am
6-K
vw1k8rs80j6oy3cdu
6 Oct 23
Intellipharmaceutics Reports Director Election Results
11:33am
6-K
47uiub3 b04r6b
26 Sep 23
Current report (foreign)
5:29pm
6-K
v2fknkpu
26 Sep 23
Current report (foreign)
5:23pm
6-K
ab7abz
14 Oct 22
Current report (foreign)
4:22pm
6-K
m9ljux
21 Jul 22
Current report (foreign)
5:28pm
6-K
iw1b 8imgkz4nbkkc5cf
15 Jul 22
Primary Document
8:05am
6-K
8jq6flu
27 May 22
Intellipharmaceutics Reports Director Election Results
4:49pm
20-F/A
x9mhg8kd145
6 May 22
Annual report (foreign) (amended)
7:54pm
6-K
x6nxq
29 Apr 22
Annual & Special Meeting of Shareholders
11:43am